adplus-dvertising
Connect with us

Business

Ottawa must secure rapid test kits, Oxford vaccine for Canadians: expert – Global News

Published

 on


The federal government needs to do more to secure access to rapid, at-home coronavirus test kits and the vaccine candidate being developed at the University of Oxford for Canadians, says one epidemiologist.

Both are measures that will help limit the impact of some of the early mistakes the government has made, said the University of Ottawa’s Dr. Raywat Deonandan in an interview with The West Block‘s Mercedes Stephenson.

“It’s clear now that we probably should have closed the borders earlier, we probably should’ve mandated mask wearing earlier. We should’ve compelled provinces to stop March break travel earlier,” he said.

“There are things we could’ve done. But I’m forgiving of those mistakes because that was based on the information we had at the time.”

“There are things we can do still to overcome the failures made so far.”

Story continues below advertisement

Key among those are securing access to the coronavirus vaccine candidate being developed by the University of Oxford and AstraZeneca, as well as making at-home and rapid test kits easier to get.

READ MORE: Health Canada now willing to consider at-home COVID-19 tests

Deonandan said it strikes him as a mistake that the government has so far failed to secure access to the AstraZeneca vaccine and that despite a pause on the trial last week, it remains a promising candidate.

He noted the researchers have been pro-active in disclosing large amounts of raw data from their trials in contrast to researchers who worked on a Russian vaccine candidate whose legitimacy has come under repeated questioning over a lack of large-scale testing and lack of transparent data.

“People need to understand that to do this right is going to take some time,” he said. “The fact the AstraZeneca trial was paused is a good thing. It means they’re taking safety seriously.”

The AstraZeneca vaccine trial was paused after one woman reported neurological symptoms that so far remain unexplained. It’s the second such pause for the trial, which was briefly stalled earlier in the summer after another individual reported neurological symptoms.

READ MORE: AstraZeneca expects coronavirus vaccine result by year-end if trials resume soon

However, the cause of those symptoms ended up being an undiagnosed case of multiple sclerosis.

Story continues below advertisement

The pharmaceutical firm has said it still expects to know by the end of this year if its vaccine candidate works — if it is able to resume trials shortly.

So far, the government has signed agreements with Novavax, Pfizer, Moderna and Johnson & Johnson.

Those deals say the government will get up to 38 million doses from Johnson & Johnson, up to 76 million from Novavax, up to 56 million from Moderna and a minimum of 20 million doses from Pfizer.

Deonandan said he is always hesitant when it comes to making predictions but offered a cautious one.

“I think it’s likely that we’ll have a viable candidate on the market on the world stage by the middle of next year, if not a bit earlier,” he said.

“With deployment, transportation, immune response, we may have sufficient numbers of people vaccinated to start thinking about not declaring the pandemic by the end of 2021, maybe the beginning of 2022, we’ll start seeing the pandemic being something in the past.”






1:09
Coronavirus: U.K. says pause on Oxford vaccine clinical trial ‘not unusual’


Coronavirus: U.K. says pause on Oxford vaccine clinical trial ‘not unusual’

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

Business

Canada Goose to get into eyewear through deal with Marchon

Published

 on

 

TORONTO – Canada Goose Holdings Inc. says it has signed a deal that will result in the creation of its first eyewear collection.

The deal announced on Thursday by the Toronto-based luxury apparel company comes in the form of an exclusive, long-term global licensing agreement with Marchon Eyewear Inc.

The terms and value of the agreement were not disclosed, but Marchon produces eyewear for brands including Lacoste, Nike, Calvin Klein, Ferragamo, Longchamp and Zeiss.

Marchon plans to roll out both sunglasses and optical wear under the Canada Goose name next spring, starting in North America.

Canada Goose says the eyewear will be sold through optical retailers, department stores, Canada Goose shops and its website.

Canada Goose CEO Dani Reiss told The Canadian Press in August that he envisioned his company eventually expanding into eyewear and luggage.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GOOS)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

TD CEO to retire next year, takes responsibility for money laundering failures

Published

 on

 

TORONTO – TD Bank Group, which is mired in a money laundering scandal in the U.S., says chief executive Bharat Masrani will retire next year.

Masrani, who will retire officially on April 10, 2025, says the bank’s, “anti-money laundering challenges,” took place on his watch and he takes full responsibility.

The bank named Raymond Chun, TD’s group head, Canadian personal banking, as his successor.

As part of a transition plan, Chun will become chief operating officer on Nov. 1 before taking over the top job when Masrani steps down at the bank’s annual meeting next year.

TD also announced that Riaz Ahmed, group head, wholesale banking and president and CEO of TD Securities, will retire at the end of January 2025.

TD has taken billions in charges related to ongoing U.S. investigations into the failure of its anti-money laundering program.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending